Participate in a Study 

register_now_copy

Current Studies

Type 1 Diabetes Trials:

Study - Glitter 1

  • Arm 1 - 26 weeks / 5 phone visits / 9 office visits
  • Arm 2 - 52 weeks / 5 phone visits / 17 office visits
  • Subjects with a confirmed diagnosis of type 1 diabetes mellitus who have been on an approved basal and bolus insulin regimen for at least 6 months (the type or brand of insulin should not have changed in the 6 months before screening)
  • HbA1c < 11.0%
  • BMI ≥ 19 kg/m2 and ≤ 35 kg/m2

Type 2 Diabetes Trials:

Study - EFC14875

  • 1 year / 15 office visits / 16 phone visits
  • Type 2 diabetes with HbA1c ≥7% (53 mmol/mol) at Screening
  • Patients either:
    • Age ≥18 years with at least 1 (one) of the major CV risk factor
    • OR
    • In the absence of a major CV risk factor, age ≥55 years with at least 2 (two)of minor CV risk factors
 
Endocrine Research Solutions, Inc.
1475 Holcomb Bridge Road, Suite 129, Roswell, GA 30076
Ph: 678.878.4750 Fx: 678.878.4751